The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The innovation is particularly suited for bone and cartilage repair
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
